Latest China Telecom Corp Ltd (CHA) Headlines China

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest China Telecom Corp Ltd (CHA) Headlines

China Telecom Has Returned 15.3% Since SmarTrend Recommendation (CHA)
Comtex SmarTrend(R) - Fri Mar 07, 5:10PM CST
SmarTrend identified a Downtrend for China Telecom (NYSE:CHA) on December 11th, 2013 at $50.64. In approximately 3 months, China Telecom has returned 15.30% as of today's recent price of $42.89.

Updated Research Report on China Unicom - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 5:50PM CST
On Mar 5, 2014, we issued an updated research report on China Unicom Hong Kong Limited.

ChitrChatr Congratulates WhatsApp on Its Acquisition by Facebook For $19 Billion
Filing Services Canada - Thu Mar 06, 6:00AM CST
ChitrChatr Communications Inc. (CSE:CHA, FRA:CA9, OTC:CHICF),(www.chitrchatr.com), a world leader in developing and marketing Comprehensive Universal Unified Communications Platform (CUUCP), congratulates WhatsApp on being acquired by Facebook as announced late Wednesday, February 19, 2014. We compare ChitrChatr to WhatsApp.

Skyworks Stock Price Target Hiked On China 4G
at Investor's Business Daily - Mon Mar 03, 12:47PM CST
China's buildout of 4G wireless data service will give analog chip maker Skyworks Solutions (SWKS) an opportunity to ramp up already large sales in that country, says Canaccord Genuity, which hiked its price target on Skyworks stock on Monday. Shares...

China Unicom Top & Bottom Lines Soar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 12:20PM CST
China Unicom announced the results for full-year 2013 with adjusted net income of RMB 10.4 billion ($1.68 billion)

Shares of CHA Down 14.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Feb 28, 11:19AM CST
SmarTrend identified a Downtrend for China Telecom (NYSE:CHA) on December 11th, 2013 at $50.64. In approximately 3 months, China Telecom has returned 14.42% as of today's recent price of $43.34.

China Telecom Down 10.5% Since SmarTrend Downtrend Call (CHA)
Comtex SmarTrend(R) - Fri Feb 21, 10:07AM CST
SmarTrend identified a Downtrend for China Telecom (NYSE:CHA) on December 11th, 2013 at $50.64. In approximately 2 months, China Telecom has returned 10.53% as of today's recent price of $45.31.

How Apple's iPhone Is Already Helping China Mobile
at The Street - Thu Feb 20, 11:58AM CST
Fear not Apple fans. It looks like the iPhone launch for China Mobile is already playing out better than anyone thought.

Apple's iPhone Is Growing in China
Rick Munarriz, The Motley Fool - Motley Fool - Wed Feb 19, 2:30PM CST
The market wasn't impressed that Apple sold only 51 million iPhones during the holiday quarter, but a lot of those shiny new devices made their way out to China.  Industry tracker IDC is reporting that Apple's share of China's smartphone market...

Alliance Media Group Holdings, Inc Announces the Appointment of Joe McNaney as CEO of AMG Renewables
Marketwire - Tue Feb 11, 8:05AM CST
Alliance Media Group Holdings, Inc. (OTCQB: ALLM) (the "Company") announced today that Joe McNaney of CellMark has been appointed CEO of its wholly owned subsidiary AMG Renewables, LLC (www.amgrenewables.com). As Executive Vice President of CellMark, a privately owned forest paper product and renewable energy company, McNaney leads the organizations sales efforts and has been instrumental in the development of their long-term strategic goals. McNaney has extensive experience in the chemical industry, forest paper products industry as well as the renewable energy industry. In 2010 CellMark acquired Alcan International, adding chemicals and minerals to the CellMark line up and in 2008 McNaney started CellMark Energy, a division of CellMark that is focused on producing green energy. Before joining CellMark McNaney had held senior sales and management positions at Hoechst, Champion International, Ris Paper and Walters Wilcox and Furlong.

Upgrade Alert for China Telecom (CHA)
Comtex SmarTrend(R) - Fri Feb 07, 7:06AM CST
China Telecom (NYSE:CHA) was upgraded from Neutral to Outperform at Credit Suisse (pre-open) today. The stock closed yesterday at $46.18 on volume of 61,000 shares, below average daily volume of 67,000. China Telecom Corporation Limited, through its subsidiaries, provides wireline telephone, data, and Internet, as well as leased line services in China.

China Telecom Shares Down 9.5% Since SmarTrend's Sell Call (CHA)
Comtex SmarTrend(R) - Thu Feb 06, 9:31AM CST
SmarTrend identified a Downtrend for China Telecom (NYSE:CHA) on December 11th, 2013 at $50.64. In approximately 2 months, China Telecom has returned 9.46% as of today's recent price of $45.85.

China's Internet Giants Vie to Win Income From Mobile Games
at The Street - Fri Jan 31, 5:00AM CST
China's rabid gamers may not notice the accumulating charges on their cellphones, but the nation's top mobile Internet companies do.

VMware's Q4 Earnings Up Y/Y, Revs Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 12:04PM CST
VMware's earnings increased in the fourth quarter, revenues slightly better than the Zacks Consensus Estimate

Is China Telecom (CHA) Ready to Breakout? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 6:32AM CST
Is China Telecom (CHA) Ready to Breakout?

Emerging Market Sell-Off Hits Telecom, Web Stocks
at Investor's Business Daily - Fri Jan 24, 10:46AM CST
The sell-off in emerging market currencies on Friday drove down shares of Vodafone (VOD), Telefonica (TEF), America Movil (AMX), VimpelCom (VIP), satellite TV broadcaster DirecTV Group (DTV) and Latin American e-commerce firm MercadoLibre (MELI), as...

How Apple Intends to Dominate in 2014
Bob Ciura, The Motley Fool - Motley Fool - Tue Jan 21, 1:00PM CST
The stage is set for Apple to blow away expectations in fiscal 2014. Investors have many reasons to be excited for what the upcoming year holds, including what's likely to have been a great holiday quarter, and the much-awaited deal with China...

Apple’s iPhone Gets Cheaper in China
Andrew Tonner, The Motley Fool - Motley Fool - Tue Jan 07, 7:00PM CST
Apple 's iconic iPhone is set to debut on telecom behemoth China Mobile in just 10 days. The introduction of Apple's iPhone on China Mobile's 3G and 4G networks has been widely expected to generate its fair share of ripple effects throughout...

Why I'm Not Worried About iPhone Pre-Orders in China
Adam Levy, The Motley Fool - Motley Fool - Thu Jan 02, 1:15PM CST
In a market that buys more smartphones than the U.S. has people, 100,000 phones is just a small drop in the bucket. It's also the number of pre-orders China Mobile took for Apple 's latest iPhones in its first two days of availability, according...

China Mobile iPhone debut dud
at Investor's Business Daily - Mon Dec 30, 5:37PM CST
Pre-orders for Apple (AAPL) iPhones on China Mobile (CHL) are weak, according to a report out Mon. On Dec. 12, Apple announced a long-expected distribution deal with China Mobile, the world's largest wireless carrier. But Wedge Partners said Mon....

China Telecom Corp. Ltd. (CHA) Stock Research Links

CHA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 5

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 1

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

CAPREIT Welcomes Francine Moore to Board of Trustees

Updated Category News Views 162

CAPREIT Welcomes Francine Moore to Board of Trustees CAPREIT is excited to share that Ms. Francine Moore has been appointed as a new member of its Board of Trustees. This appointment took effect on November 7. Francine is known for her significant experience in the real estate sector, where she has built a remarkable career. Ms. Moore's Impressive Background With over 25...

Continue Reading
Cimpress Sees Target Adjustments Yet Remains Strong – A Deeper Look

Updated Category News Views 95

Cimpress Stock Target Adjustments and Outlook Recently, Truist Securities made notable adjustments to the stock price target for Cimpress N.V. (NASDAQ: CMPR), a recognized leader in mass customization solutions. The new target is now set at $110.00, reduced from the previous $120.00. Despite this adjustment, the firm has reiterated a Buy rating, showcasing confidence in...

Continue Reading
Significant Shift in NICUs: Embracing Prolacta's Innovations

Updated Category News Views 131

Transforming Neonatal Care with Prolacta's Nutritional Innovations Prolacta Offers the Only Nutritional Products Free From Cow Milk and Added Synthetic Ingredients for Extremely Premature Infants in the U.S. In an exciting development for neonatal care, Prolacta Bioscience® has reported that in 2025, the majority of Level III and IV neonatal intensive care units (NICUs)...

Continue Reading
Orchestry Unveils Automated Workspace Solutions for Microsoft 365

Updated Category News Views 127

Orchestry Launches Innovative Workspace Review for Teams and SharePoint Orchestry has introduced a groundbreaking feature that aims to transform the way IT administrators manage collaboration workspaces within Microsoft 365. This new capability, known as Workspace Review, not only automates the maintenance of these workspaces but also enhances security and compliance...

Continue Reading
The Investment Journey of Webster Financial Over Five Years

Updated Category News Views 151

Understanding Webster Financial's Growth Over the Years Webster Financial (NYSE: WBS) has demonstrated remarkable performance in the stock market, consistently outperforming many competitors. Over the past five years, it has achieved an impressive average annual return of 15.04%, surpassing the market by 1.25% annually. This impressive growth reflects the ongoing...

Continue Reading